Ceetox Names Dr. Colleen Toole As Director Of Project Management

March 5, 2009 - PRLog -- CeeTox Inc, the Kalamazoo-based leader for in vitro toxicity testing, has selected Colleen Toole Ph.D. as Director of Project Management.  Dr. Toole, in the newly-created position, is the Scientific Leader for the services division, and manages the progress of all CeeTox client studies as well as providing internal technical liaison.

Prior to joining CeeTox, Dr. Toole served as Director of Molecular Biology at Cayman Chemical Company where she initiated and directed the molecular biology/protein expression core group and was promoted to Manager of Preclinical Drug Discovery. Previously, Dr. Toole was Team Leader for the AKT project at Amphora Discovery in Research Triangle Park, North Carolina.

“I am excited to join this dynamic team and contribute to the leading edge of in vitro toxicology,” said Dr. Toole. “CeeTox’s body of work with pharmaceutical clients, plus our new screens that use 3D cells models to replace the need to test with animals, impressed me. CeeTox's innovations are based on the best science.”

Using a robust, systems-biology approach, CeeTox developed predictive in vitro models that help identify new drug candidates, chemicals, cosmetics, and consumer products with the lowest risk for toxicity and the highest probability of success. With screens to assess corrosion, irritation, sensitization, endocrine disruption, photosensitivity, and to characterize toxicity in drugs and chemicals, CeeTox supports manufacturers in the pharmaceutical, chemical, and cosmetic industries. CeeTox helps bring safer products to market faster.

For more information, contact CeeTox at +1-269-353-5555 or info@ceetox.com.

# # #

CeeTox leads the field of in-vitro toxicology with predictive models that utilize a robust systems-biology approach and enable our clients to make better decisions, earlier in discovery, to bring safer products to market, faster. Has it been CeeTox'd?